The Wegovy maker wants the federal government to show more ambition and open a quick, practical route to affordable treatment for patients.
Recap by typeshit. Full story at The Australian.
Medicare open enrollment has started, and plan changes include newly negotiated drug prices and lower costs on some medications.
Prescriptions roll out in phases from the 29th, starting at 129,800 won for four weeks. Hanmi reported 9.75% average weight loss at 40 weeks in a phase 3 interim analysis.
Parker argues patients can spend two weeks fighting for coverage of one GLP-1 without learning another brand might cost them nothing.
Millions of Medicare beneficiaries may want in on the GLP-1 Bridge program, but eligibility rules mean not everyone will qualify.
Medscape covers trial results linking an experimental medication to a major drop in obstructive sleep apnea severity. Tap through for the drug and the data.
New generics and steady prices drove the jump in value despite fewer units sold, with Eli Lilly's tirzepatide featured in the breakdown.
Loading…